Article info

Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure

Authors

  1. Correspondence to Dr Gerd-Rüdiger R Burmester, Universitatsklinikum Charite, Berlin, Germany; gerd.burmester{at}charite.de
View Full Text

Citation

Deodhar AA, Combe B, Accioly AP, et al
Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure

Publication history

  • Received December 17, 2021
  • Accepted March 15, 2022
  • First published April 7, 2022.
Online issue publication 
June 10, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.